Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Rational drug use in the treatment of depression
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rational drug use in the treatment of depression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antidepressants
100%
Depression Treatment
100%
Monoamine Oxidase Inhibitors
100%
Selective Serotonin Reuptake Inhibitors
100%
Rational Drug Use
100%
Drug Interactions
50%
Mechanism of Action
50%
Complete Remission
50%
Adverse Effects
50%
Clinically Significant
50%
Depression Level
50%
Disability
50%
Early Response
50%
Tricyclic Antidepressants
50%
Venlafaxine
50%
New Drugs
50%
Side Effect Profile
50%
Agitation
50%
Dosing Schedule
50%
Pharmacoeconomics
50%
Response to Therapy
50%
Atypical Depression
50%
New Agents
50%
Nefazodone
50%
Long-term Tolerability
50%
Underlying Medical Conditions
50%
Psychotic Features
50%
Sleep Loss
50%
Unipolar Depression
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Selective Serotonin Reuptake Inhibitor
100%
Disease
100%
Monoamine Oxidase Inhibitor
100%
Tolerability
50%
Adverse Event
50%
Side Effect
50%
Remission
50%
Prevalence
50%
Venlafaxine
50%
Tricyclic Antidepressant
50%
Major Depression
50%
Drug Interaction
50%
Pharmacoeconomics
50%
Atypical Depression
50%
Nefazodone
50%